Defective myelination in an RNA polymerase III mutant leukodystrophic mouse

Emilio Merheb1, Min-Hui Cui2,3, Juwen C DuBois4

  • 1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461.

Insights

Mutations in RNA polymerase III (Pol III) cause neurodegenerative disease. Mice with Pol III gene mutations in specific brain cells show developmental delays and hypomyelination, revealing insights into leukodystrophy pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • RNA polymerase III (Pol III) synthesizes vital short noncoding RNAs.
  • Mutations in Pol III subunits lead to Pol III-related leukodystrophy, a severe early-onset neurodegenerative disease.
  • The neural basis and disease mechanisms remain poorly understood.

Purpose of the Study:

  • To investigate the role of Pol III in neural development and disease.
  • To model Pol III-related leukodystrophy using conditional mouse mutants.

Main Methods:

  • Generated mice with pathogenic mutations in the largest Pol III subunit (Polr3a) specifically in Olig2-expressing cells.
  • Assessed growth, development, cognitive, sensory, and sensorimotor functions.
  • Examined myelination in the cerebrum and spinal cord.

Main Results:

  • Conditional mice exhibited impaired growth, developmental delay, and functional deficits.
  • Hypomyelination was observed in multiple brain and spinal cord regions.
  • Oligodendrocyte development and myelin sheath formation were impaired.

Conclusions:

  • Perturbations in Pol III transcription uniquely affect oligodendrogenesis and myelination.
  • This study provides a conditional model for understanding Pol III-related leukodystrophy.
  • The findings highlight the critical role of Pol III in maintaining neural health and myelin integrity.

Related Concept Videos